Clinical trials for SSRIs (selective serotonin reuptake inhibitors)

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to SSRIs (selective serotonin reuptake inhibitors). For all clinical trials, go to clinical trials search

This list shows clinical trials for SSRIs (selective serotonin reuptake inhibitors)

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • SSRIs (selective serotonin reuptake inhibitors)
Title Recruitment status Location
Effect of Antenatal SSRI Exposure on the QT Interval of Neonates Recruiting United Kingdom
Cardiac Control of Fear in Brain: relationship to anxiety symptoms Recruiting United Kingdom
A randomised controlled feasibility trial comparing clinical and cost effectiveness of cognitive behavioural therapy (CBT) and selective serotonin reuptake inhibitors (SSRI) and their combination in the management of obsessive compulsive disorder. Recruiting United Kingdom
Proof of concept study to evaluate the effect of AFQ056 in obsessive compulsive disorder (OCD) patients resistant to Selective Serotonin Reuptake Inhibitor (SSRI) therapy Not Recruiting United Kingdom
A Study of Flexible Dose LY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment Not Recruiting United Kingdom
Proof of concept study to evaluate the effect of AFQ056 in obsessive compulsive disorder (OCD) patients resistant to Selective Serotonin Reuptake Inhibitor (SSRI) therapy Not Recruiting United Kingdom
Proof of concept study to evaluate the effect of AFQ056 in obsessive compulsive disorder (OCD) patients resistant to Selective Serotonin Reuptake Inhibitor (SSRI) therapy Not Recruiting United Kingdom
Effects of agomelatine on sleep electroencephalogram parameters compared to selective serotonin reuptake inhibitors in patients with major depressive disorder: a six-week randomised, double-blind parallel group study versus comparator, followed by a double-blind optional treatment extension period up to six months Not Recruiting United Kingdom
A Study of Flexible Dose LY2216684 as Adjunctive Treatment for Patients With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment Not Recruiting United Kingdom
Mirtazapine for treatment resistant depression Not Recruiting United Kingdom

Page last reviewed: 20/11/2015

Next review due: 01/11/2018